Tandospirone, sold under the brand name Sediel, is an anxiolytic and antidepressant medication used in Japan and China, where it is marketed by Dainippon Sumitomo Pharma. It is a member of the azapirone class of drugs and is closely related to other azapirones such as buspirone and gepirone. Pharmacologically tandospirone functions primarily as a serotonin 5-HT1A receptor partial agonist with relatively low affinity for dopamine D2 receptors; its pharmacodynamic profile includes modulation of serotonergic tone and downstream effects on noradrenergic circuits via its principal metabolite 1-(2-pyrimidinyl)piperazine, which has alpha-2 adrenergic antagonism. The molecule is orally active, undergoes hepatic metabolism to polar and dealkylated metabolites, and produces anxiolytic and antidepressant effects without the typical benzodiazepine-associated sedation and dependence liability seen with GABAergic agents.
Parent: Tandospirone
Parent: Tandospirone
Parent: Tandospirone
Typical quality specifications for tandospirone active pharmaceutical ingredient control related substances and impurities according to common industry practice: individual known related compounds, including 1-(2-pyrimidinyl)piperazine, dealkylated and hydroxylated derivatives, and specific synthetic intermediates, are usually limited to not more than 0.5 percent each; total related substances are commonly limited to not more than 1.0 percent. Genotoxic or unexpected impurities are controlled at much lower thresholds, commonly 0.05 percent or lower for any single genotoxic impurity, with qualification and identification carried out per ICH guidelines. Additional quality parameters include residual solvents within ICH Q3C limits, heavy metals typically below 10 to 20 ppm, and water content consistent with the chosen polymorph and drying specification.
Tandospirone is an azapirone-class anxiolytic and antidepressant used clinically in Japan and China; it is a 5-HT1A receptor partial agonist that reduces anxiety and improves mood by modulating serotonergic neurotransmission and related neural circuits.
Common adverse effects include dizziness, drowsiness or somnolence, nausea, headache, gastrointestinal upset, and occasional dry mouth; it has a lower risk of dependence and cognitive impairment than benzodiazepines but can interact with CNS depressants and should be used cautiously with other serotonergic agents.
Tandospirone exerts its primary pharmacological action as a partial agonist at serotonin 5-HT1A receptors, producing anxiolytic and antidepressant effects by modulating serotonergic autoreceptors and postsynaptic signaling; its major metabolite 1-(2-pyrimidinyl)piperazine contributes to effects on noradrenergic tone through alpha-2 adrenergic antagonism.
